Laman Utama207940 • KRX
add
Samsung Biologics Co Ltd
Tutup sebelumnya
₩1,027,000.00
Julat hari
₩1,037,000.00 - ₩1,131,000.00
Julat tahun
₩907,000.00 - ₩1,209,000.00
Permodalan pasaran
80.21T KRW
Bilangan Purata
64.58K
Nisbah P/E
62.38
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.29T | 11.50% |
Perbelanjaan pengendalian | 239.48B | 8.55% |
Pendapatan bersih | 324.39B | 2.01% |
Margin untung bersih | 25.15 | -8.51% |
Pendapatan bagi setiap syer | 4.56K | 2.01% |
EBITDA | 653.80B | 12.23% |
Kadar cukai berkesan | 20.67% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.64T | 4.85% |
Jumlah aset | 17.77T | 8.75% |
Jumlah liabiliti | 6.17T | 2.60% |
Jumlah ekuiti | 11.60T | — |
Syer tertunggak | 71.17J | — |
Harga kepada buku | 6.30 | — |
Pulangan pada aset | 6.75% | — |
Pulangan pada modal | 9.25% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 324.39B | 2.01% |
Tunai daripada operasi | 523.38B | 118.57% |
Tunai daripada pelaburan | -540.29B | -70.43% |
Tunai daripada pembiayaan | -2.62B | 91.92% |
Perubahan bersih dalam tunai | -42.58B | 50.81% |
Aliran tunai bebas | 251.99B | 144.79% |
Perihal
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
CEO
Diasaskan
2011
Tapak web
Pekerja
5,047
